Chan Feng

3.9k total citations · 1 hit paper
44 papers, 3.3k citations indexed

About

Chan Feng is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Chan Feng has authored 44 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Biomedical Engineering, 21 papers in Molecular Biology and 16 papers in Materials Chemistry. Recurrent topics in Chan Feng's work include Nanoplatforms for cancer theranostics (22 papers), RNA Interference and Gene Delivery (7 papers) and Nanoparticle-Based Drug Delivery (7 papers). Chan Feng is often cited by papers focused on Nanoplatforms for cancer theranostics (22 papers), RNA Interference and Gene Delivery (7 papers) and Nanoparticle-Based Drug Delivery (7 papers). Chan Feng collaborates with scholars based in China, United States and South Korea. Chan Feng's co-authors include Wei Tao, Na Kong, Jiang Ouyang, Xiaoyuan Ji, Zhongmin Tang, Xingcai Zhang, Omid C. Farokhzad, Chuang LIU, Chunyan Dong and Tian Xie and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Angewandte Chemie International Edition.

In The Last Decade

Chan Feng

44 papers receiving 3.3k citations

Hit Papers

In situ sprayed NIR-responsive, analgesic black phosphoru... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. In situ sprayed NIR-responsive, analgesic black phosphorus-based gel for diabetic ulcer treatment
    2020 308 citations Jiang Ouyang, Xiaoyuan Ji et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chan Feng China 30 1.9k 1.1k 1.0k 772 345 44 3.3k
Ke Li China 30 1.8k 1.0× 803 0.8× 659 0.6× 817 1.1× 466 1.4× 89 3.0k
Mei‐Zhen Zou China 25 2.4k 1.2× 895 0.8× 974 0.9× 887 1.1× 666 1.9× 36 3.4k
Baojin Ma China 33 2.4k 1.2× 819 0.8× 1.4k 1.4× 858 1.1× 158 0.5× 87 3.9k
Yelin Wu China 31 1.3k 0.7× 717 0.7× 855 0.8× 461 0.6× 427 1.2× 84 2.9k
Muchao Chen China 22 2.2k 1.2× 639 0.6× 1.1k 1.1× 822 1.1× 349 1.0× 30 2.9k
Jiawen Chen China 26 2.5k 1.3× 774 0.7× 1.0k 1.0× 892 1.2× 551 1.6× 89 3.6k
Dong Gil You South Korea 32 2.0k 1.1× 1.2k 1.1× 886 0.9× 1.1k 1.4× 304 0.9× 75 3.7k
Chenggen Qian China 32 2.1k 1.1× 1.1k 1.0× 1.1k 1.1× 1.0k 1.3× 332 1.0× 54 3.6k
Muhammad Rizwan Younis China 37 2.4k 1.2× 1.1k 1.1× 1.8k 1.7× 509 0.7× 183 0.5× 103 3.9k
Zimu Li China 22 1.6k 0.9× 673 0.6× 720 0.7× 910 1.2× 226 0.7× 45 2.9k

Countries citing papers authored by Chan Feng

Since Specialization
Citations

This map shows the geographic impact of Chan Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chan Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chan Feng more than expected).

Fields of papers citing papers by Chan Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chan Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chan Feng. The network helps show where Chan Feng may publish in the future.

Co-authorship network of co-authors of Chan Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Chan Feng. A scholar is included among the top collaborators of Chan Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chan Feng. Chan Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Fan, et al.. (2024). Nanobiotechnology boosts ferroptosis: opportunities and challenges. Journal of Nanobiotechnology. 22(1). 606–606. 12 indexed citations
2.
Yi, Yunfei, Chan Feng, Mian Yu, et al.. (2023). Peptide-based siRNA delivery system for tumor vascular normalization and gene silencing in 4T1 cells. STAR Protocols. 4(1). 102138–102138. 3 indexed citations
3.
Jiang, Tianyue, et al.. (2023). Study on Mechanical Properties and Penetration Stability of DNAN Based Explosives Under Additive Effects. Journal of Physics Conference Series. 2478(3). 32037–32037. 1 indexed citations
4.
Kang, Yong, Hanjie Zhang, Li‐Qun Chen, et al.. (2022). The marriage of Xenes and hydrogels: Fundamentals, applications, and outlook. The Innovation. 3(6). 100327–100327. 34 indexed citations
5.
Feng, Chan, Yongjiang Li, Bijan Emiliano Ferdows, et al.. (2022). Emerging vaccine nanotechnology: From defense against infection to sniping cancer. Acta Pharmaceutica Sinica B. 12(5). 2206–2223. 76 indexed citations
6.
Zhao, Hao, Jiabao Xu, Chan Feng, et al.. (2021). Tailoring Aggregation Extent of Photosensitizers to Boost Phototherapy Potency for Eliciting Systemic Antitumor Immunity. Advanced Materials. 34(8). e2106390–e2106390. 114 indexed citations
7.
Tang, Zhongmin, Yufen Xiao, Na Kong, et al.. (2021). Nano-bio interfaces effect of two-dimensional nanomaterials and their applications in cancer immunotherapy. Acta Pharmaceutica Sinica B. 11(11). 3447–3464. 45 indexed citations
8.
Pan, Wen, Chuang LIU, Yunhui Li, et al.. (2021). Ultrathin tellurium nanosheets for simultaneous cancer thermo-chemotherapy. Bioactive Materials. 13. 96–104. 34 indexed citations
9.
Ouyang, Jiang, Ling Zhang, Lei‐Jiao Li, et al.. (2021). Cryogenic Exfoliation of 2D Stanene Nanosheets for Cancer Theranostics. Nano-Micro Letters. 13(1). 90–90. 58 indexed citations
10.
Liu, Yanjie, Yan Zou, Chan Feng, et al.. (2020). Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy. Nano Letters. 20(3). 1637–1646. 145 indexed citations
11.
Tao, Wei, Arif Yurdagul, Na Kong, et al.. (2020). siRNA nanoparticles targeting CaMKIIγ in lesional macrophages improve atherosclerotic plaque stability in mice. Science Translational Medicine. 12(553). 191 indexed citations
12.
Shi, Sanjun, Na Kong, Chan Feng, et al.. (2019). Drug Delivery Strategies for the Treatment of Metabolic Diseases. Advanced Healthcare Materials. 8(12). e1801655–e1801655. 47 indexed citations
13.
14.
Feng, Chan, Lv Chen, Yonglin Lu, et al.. (2019). Programmable Ce6 Delivery via Cyclopamine Based Tumor Microenvironment Modulating Nano-System for Enhanced Photodynamic Therapy in Breast Cancer. Frontiers in Chemistry. 7. 608312–608312. 12 indexed citations
15.
16.
Ling, Xiang, Jiasheng Tu, Junqing Wang, et al.. (2018). Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy. ACS Nano. 13(1). 357–370. 227 indexed citations
17.
Feng, Chan, Kun Wang, Yun Lin, et al.. (2018). Extracellular retention of a cyclopamine nanoformulation leveraging larger size and more negative charge for improved breast cancer treatment. Journal of Materials Chemistry. 1 indexed citations
18.
Song, Zhiwang, Chan Feng, Yonglin Lu, Yun Lin, & Chunyan Dong. (2017). PHGDH is an independent prognosis marker and contributes cell proliferation, migration and invasion in human pancreatic cancer. Gene. 642. 43–50. 69 indexed citations
19.
Song, Zhiwang, Chuan Shao, Chan Feng, et al.. (2016). Association of glutathione S-transferase T1, M1, and P1 polymorphisms in the breast cancer risk: a meta-analysis. Therapeutics and Clinical Risk Management. 12. 763–763. 23 indexed citations
20.
Dong, Chunyan, Chan Feng, Xiaoyan Li, et al.. (2015). RGD-modified liposomes enhance efficiency of aclacinomycin A delivery: evaluation of their effect in lung cancer. Drug Design Development and Therapy. 9. 4613–4613. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ke Li Breakdown of academic impact, for papers by Mei‐Zhen Zou Breakdown of academic impact, for papers by Baojin Ma Breakdown of academic impact, for papers by Yelin Wu Breakdown of academic impact, for papers by Muchao Chen Breakdown of academic impact, for papers by Jiawen Chen Breakdown of academic impact, for papers by Dong Gil You Breakdown of academic impact, for papers by Chenggen Qian Breakdown of academic impact, for papers by Muhammad Rizwan Younis Breakdown of academic impact, for papers by Zimu Li
Rankless by CCL
2026